Biomerica (BMRA) Profit After Tax (2010 - 2026)
Biomerica (BMRA) reported Profit After Tax of -$1.3 million for Q1 2026, down 12.71% on a YoY basis from -$1.5 million in Q1 2025, and up 0.61% sequentially from -$1.3 million in Q4 2025.
Biomerica (BMRA) Profit After Tax (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 17 years of Profit After Tax data on file, last reported at -$1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 12.71% year-over-year to -$1.3 million; the trailing twelve-month figure through Feb 2026 stood at -$4.2 million (up 14.26% YoY), and the FY2025 full-year result was -$5.0 million, up 16.76% from the prior year.
- Profit After Tax grew to -$1.3 million in Q1 2026, from -$1.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $2000.0 in Q3 2025 to a low of -$2.1 million in Q3 2022.
- A 5-year average of -$1.3 million and a median of -$1.4 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax tumbled 1460.36% in 2023 and jumped 100.15% in 2025, its largest moves.
- Tracing BMRA's Profit After Tax over 5 years: stood at -$1.6 million in 2022, then rose by 7.32% to -$1.5 million in 2023, then jumped by 36.96% to -$950000.0 in 2024, then sank by 38.95% to -$1.3 million in 2025, then increased by 0.61% to -$1.3 million in 2026.
- Business Quant data shows BMRA's Profit After Tax at -$1.3 million in Q1 2026, -$1.3 million in Q4 2025, and $2000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1.31 Mn |
| Nov 30, 2025 | -1.32 Mn |
| Aug 31, 2025 | 2,000.00 |
| May 31, 2025 | -1.54 Mn |
| Feb 28, 2025 | -1.16 Mn |
| Nov 30, 2024 | -950,000.00 |
| Aug 31, 2024 | -1.32 Mn |
| May 31, 2024 | -1.43 Mn |
| Feb 29, 2024 | -1.92 Mn |
| Nov 30, 2023 | -1.51 Mn |
| Aug 31, 2023 | -1.13 Mn |
| May 31, 2023 | -1.79 Mn |
| Feb 28, 2023 | -1.67 Mn |
| Nov 30, 2022 | -1.63 Mn |
| Aug 31, 2022 | -2.07 Mn |
| May 31, 2022 | -1.77 Mn |
| Feb 28, 2022 | -106,706.00 |
| Nov 30, 2021 | -1.13 Mn |
| Aug 31, 2021 | -1.54 Mn |
| May 31, 2021 | -1.70 Mn |